1-100

1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012; 126: 2020-2035.

2. Davies MJ, Thomas AC. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53:

363-373.

3. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992; 326:

242-250.

4. Rentrop KP, Blanke H, Karsch KR, et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979; 2:

354-363.

5. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med

1980; 303: 897-902.

6. Kodama K, Asakura M, Ueda Y, et al. The role of plaque rupture in the development of acute coronary syndrome evaluated by the coronary angioscope.

Intern Med 2000; 39: 333-335.

7. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction:

an angioscopic study. J Am Coll Cardiol 2001; 37: 1284-1288.

8. Libby P. Molecular bases of the acute coronary syndromes.Circulation 1995; 91: 2844-2850.

9. Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June

17 and 18, 2003, Santorini, Greece. Eur Heart J 2004; 25: 1077-1082.

10. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.

11. 泰江弘文．急性冠症候群　基礎から臨床まで；冠動脈疾患の病態解明と急性冠症候群．最新医学 1999; 54: 1165-1171.

12. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular

ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000; 35: 106-111.

13. Ueda Y, Ohtani T, Shimizu M, et al. Color of culprit lesion at 6 months after plain old balloon angioplasty versus stenting in patients with acute

myocardial infarction. Am Heart J 2004; 148: 842-846.

14. Ino Y, Kubo T, Tanaka A, et al. Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-ST-segment

elevation acute coronary syndrome: an optical coherence tomography study. JACC Cardiovasc Interv 2011; 4: 76-82.

15. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Circulation 2003; 108: 1664-1672.

16. van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized

by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.

17. Okumura K, Yasue H, Matsuyama K, et al. Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response

of the infarct-related coronary artery and that of the noninfarct-related artery. J Am Coll Cardiol 1992; 19: 752-758.

18. Forrester JS, Wyatt HL, Da Luz PL, et al. Functional significance of regional ischemic contraction abnormalities. Circulation 1976; 54: 64-70.

19. White HD, Norris RM, Brown MA, et al. Left ventricular endsystolic volume as the major determinant of survival after recovery from myocardial infarction.

Circulation 1987; 76: 44-51.

20. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81:

1161-1172.

21. Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med

1988; 319: 80-86.

22. Ceremuzynski L. Hormonal and metabolic reactions evoked by acute myocardial infarction. Circ Res 1981; 48: 767-776.

23. Cheitlin MD, McAllister HA, de Castro CM. Myocardial infarction without atherosclerosis. JAMA 1975; 231: 951-959.

24. Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between japanese and caucasians with

recent myocardial infarction. Circulation 2000; 101: 1102-1108.

25. Bertrand ME, LaBlanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary

arteriography. Circulation 1982; 65: 1299-1306.

26. Wu AH, Parsons L, Every NR, et al. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction:

a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002; 40: 1389-1394.

27. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the

INTERHEART study): case-control study. Lancet 2004; 364: 937-952.

28. Kinjo K, Sato H, Ohnishi Y, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with

percutaneous coronary intervention. Am J Cardiol 2003; 92: 1150-1154.

29. Kasanuki H, Honda T, Haze K, et al. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial

infarction in Japan: rationale and initial results of the HIJAMI Registry. Am Heart J 2005; 150: 411-418.

30. Nakamura Y, Yamamoto T, Okamura T, et al. Combined cardiovascular risk factors and outcome: NIPPON DATA80, 1980-1994. Circ J 2006; 70: 960-

964.

31. Iso H, Sato S, Kitamura A, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke

2007; 38: 1744-1751.

32. Okayama A, Kadowaki T, Okamura T, et al. Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases

among Japanese men (NIPPON DATA80). J Hypertens 2006; 24: 459-462.

33. Fujishima M, Kiyohara Y, Kato I, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes

1996; 45 Suppl 3: S14-16.

34. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The

Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.

35. Takara A, Ogawa H, Endoh Y, et al. Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization.

Cardiovasc Diabetol 2010; 9: 1.

36. Nishimura T, Nakajima K, Kusuoka H, et al. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated

myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging 2008; 35: 319-328.

37. Baba S, Iso H, Mannami T, et al. Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the

JPHC Study Cohort I. Eur J Cardiovasc Prev Rehabil 2006; 13: 207-213.

38. Iso H, Date C, Yamamoto A, et al. Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study.

Am J Epidemiol 2005; 161: 170-179.

39. Kawano H, Soejima H, Kojima S, et al. Investigators JACSSJ. Sex differences of risk factors for acute myocardial infarction in Japanese patients. Circ

J 2006; 70: 513-517.

40. Okamura T, Kadowaki T, Hayakawa T, et al. What cause of mortality can we predict by cholesterol screening in the Japanese general population? J

Intern Med 2003; 253: 169-180.

41. Imamura T, Doi Y, Arima H, et al. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese

population: the Hisayama study. Stroke 2009; 40: 382-388.

42. Lloyd-Jones DM, Nam BH, D’Agostino RB, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults:

a prospective study of parents and offspring. JAMA 2004; 291: 2204-2211.

43. Matsuzaki M, Kita T, Mabuchi H, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with

low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66: 1087-1095.

44. Furukawa Y, Ehara N, Taniguchi R, et al. Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary

revascularization. Circ J 2009; 73: 1459-1465.

45. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney

Dis 2002; 39: S1-266.

46. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:

1296-1305.

47. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis

of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.

48. Robertson TL, Kato H, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and

California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol 1977; 39: 239-243.

49. Iso H, Kobayashi M, Ishihara J, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health

Center-Based (JPHC) Study Cohort I. Circulation 2006; 113: 195-202.

50. Yamagishi K, Iso H, Date C, et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-

based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008;

52: 988-996.

51. Kokubo Y, Iso H, Ishihara J, et al. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in

Japanese populations: the Japan Public Health Centerbased (JPHC) study cohort I. Circulation 2007; 116: 2553-2562.

52. Noda H, Iso H, Toyoshima H, et al. Walking and sports participation and mortality from coronary heart disease and stroke. J Am Coll Cardiol 2005; 46:

1761-1767.

53. Rumana N, Kita Y, Turin TC, et al. Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI Registry,

1990-2001. Am J Epidemiol 2008; 167: 1358-1364.

54. Tanabe N, Saito R, Sato T, et al. Event rates of acute myocardial infarction and coronary deaths in Niigata and Nagaoka cities in Japan. Circ J 2003;

67: 40-45.

55. Sekikawa A, Ueshima H, Kadowaki T, et al. Less subclinical atherosclerosis in Japanese men in Japan than in White men in the United States in the

post-World War II birth cohort. Am J Epidemiol 2007; 165: 617-624.

56. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010; 362: 2155-

2165.

57. Takii T, Yasuda S, Takahashi J, et al. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI

Registry Study. Circ J 2010; 74: 93-100.

58. 佐藤直樹，吉田伸子，高山守正．東京都CCUネットワーク活動状況報告．ICUとCCU 2011; 35: 827-829.

59. 東京都 CCU連絡協議会事務局．東京都CCUネットワークの実績報告─2003年拡大再編成後の実績─．ICUと CCU 2005; 29: 704-709.

60. 長尾建，林成之，上松瀬勝男．虚血性突然死．日内会誌 2004; 93: 94-99.

61. SOS-KANTO Committee. Incidence of ventricular fibrillation in patients with out-of-hospital cardiac arrest in Japan. Survivors after out-of-hospital cardiac

arrest in Kanto Area (SOS-KANTO). Circ J 2005; 69: 1157-1162.

62. American Heart Association (AHA) in collaboration with International Liaison Committee on Resuscitation (ILCOR): Guidelines 2000 for cardiopulmonary

resuscitation and emergency cardiovascular care, An international consensus of science. Circulation 2000; 102: I-1-384.

63. Brodie BR, Gersh BJ, Stuckey T, et al. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with

Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty

Complications) trials. J Am Coll Cardiol 2010; 56: 407-413.

64. Shiomi H, Nakagawa Y, Morimoto T, et al; CREDO-Kyoto AMI investigators. Association of onset to balloon and door to balloon time with long term

clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study. BMJ

2012; 344: e3257.

65. 高野照夫，高山守正，子島潤，他．東京都CCUネットワークの活動状況報告と急性冠症候群の発症状況について．Ther Res 1997; 18: 2555-2560.

66. Hedges JR, Feldman HA, Bittner V, et al. Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute

myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group. Acad Emerg Med 2000; 7: 862-872.

67. Canto JG, Zalenski RJ, Ornato JP, et al. National Registry of Myocardial Infarction 2 Investigators. Use of emergency medical services in acute

myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2. Circulation 2002; 106: 3018-

3023.

68. Goldberg R, Goff D, Cooper L, et al. Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT

Trial. Rapid Early Action for Coronary Treatment. Coron Artery Dis 2000; 11: 399-407.

69. Kitamura T, Iwami T, Kawamura T, et al. Implementation Working Group for the All-Japan Utstein Registry of the Fire and Disaster Management

Agency. Nationwide public-access defibrillation in Japan. N Engl J Med 2010; 362: 994-1004.

70. Hutchings CB, Mann NC, Daya M, et al. Rapid Early Action for Coronary Treatment Study. Patients with chest pain calling 9-1-1 or self-transporting

to reach definitive care: which mode is quicker? Am Heart J 2004; 147: 35-41.

71. SOS-KANTO study group. Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study. Lancet

2007; 369: 920-926.

72. De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every

minute of delay counts. Circulation 2004; 109: 1223-1225.

73. 総務省消防庁平成21年度救急・救助の現況．http://www.fdma. go.jp/neuter/topics/houdou/2312/231216_1houdou/02_1.pdf（2012 年12月閲覧）

74. 東京消防庁．救急活動の実態，平成21年．東京消防庁　救急部編集・発行 2010: 1-123.

75. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indication for fibrinolytic therapy in suspected acute myocardial infarction: collaborative

overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-322.

76. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto

Miocardico (GISSI). Lancet 1986; 1: 397-402.

77. Armstrong PW, Collen D, Antman E. Fibrinolysis for acute myocardial infarction: the future is here and now. Circulation 2003; 107: 2533-2537.

78. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7: the era of reperfusion: section 1: acute coronary

syndromes (acute myocardial infarction). The American Heart Association in collaboration with the International Liaison Committee on Resuscitation.

Circulation 2000; 102: I172-203.

79. O’Connor RE, Brady W, Brooks SC, et al. Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary

Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122: S787-817.

80. Watanabe K, Nagao K, Watanabe I, et al. Relationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute

myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial. Circ J 2004; 68: 280-285.

81. Nakao K, Sawamura T, Katayama N, et al. Facilitated PCI as a medical service sysytem in Japan. J Jpn Coron Assoc 2005; 11: 86-90.

82. Kimura K, Tsukahara K, Usui T, et al. Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for

acute myocardial infarction treated at community hospitals. Jpn Circ J 2001; 65: 901-906.

83. Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined

Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008;

371: 559-568.

84. Cantor WJ, Fitchett D, Borgundvaag B, et al. TRANSFER-AMI Trial Investigators. Routine early angioplasty after fibrinolysis for acute myocardial

infarction. N Engl J Med 2009; 360: 2705-2718.

85. Kushner FG, Hand M, Smith SC, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial

Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating

the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on

Practice Guidelines. Circulation 2009; 120: 2271-2306.

86. Diercks DB, Kontos MC, Chen AY, et al. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation

myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes

Network) Registry. J Am Coll Cardiol 2009; 53: 161-166.

87. Scholz KH, Hilgers R, Ahlersmann D, et al. Contact-to-balloon time and door-to-balloon time after initiation of a formalized data feedback in patients

with acute ST-elevation myocardial infarction. Am J Cardiol 2008; 101: 46-52.

88. 日本蘇生協議会, 日本救急医療財団監修. JRC蘇生ガイドライン2010. へるす出版 2011.

89. 上松瀬勝男．EBMに基づく急性心筋梗塞診療ガイドライン．じほう 2001．

90. Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin

T or troponin I. N Engl J Med 1997; 337: 1648-1653.

91. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the

American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

Infarction). J Am Coll Cardiol 1996; 28: 1328-1428.

92. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction:

Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice

Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016-1030.

93. Herlitz J, Blohm M, Hartford M, et al. Delay time in suspected acute myocardial infarction and the importance of its modification. Clin Cardiol 1989; 12:

370-374.

94. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

Am J Cardiol 2003; 92: 824-826.

95. Kannel WB. Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death. Circulation 1987; 75: II4-5.

96. Grimm RH, Tillinghast S, Daniels K, et al. Unrecognized myocardial infarction: experience in the Multiple Risk Factor Intervention Trial (MRFIT).

Circulation 1987; 75: II6-8.

97. Kosuge M, Kimura K, Ishikawa T, et al. Differences between men and women in terms of clinical features of ST-segment elevation acute myocardial

infarction. Circ J 2006; 70: 222-226.

98. Patel H, Rosengren A, Ekman I. Symptoms in acute coronary syndromes: does sex make a difference? Am Heart J 2004; 148: 27-33.

99. Maynard C, Litwin PE, Martin JS, et al. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial

Infarction Triage and Intervention Registry. Arch Intern Med 1992; 152: 972-976.

100. Weaver WD, Litwin PE, Martin JS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project

Group. J Am Coll Cardiol 1991; 18: 657-662.

文献